Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

This trial is building a registry (a detailed research database) of patients with triple negative breast cancer — an aggressive type that lacks hormone and HER2 receptors — and patients with inherited gene mutations linked to breast and ovarian cancer, to better understand the disease and improve treatments. **You may be eligible if...** - You have been diagnosed with triple negative breast cancer (stages I–IV) within the past 5 years, OR - You carry a harmful gene mutation linked to hereditary breast or ovarian cancer (such as BRCA1, BRCA2, PTEN, TP53, PALB2) - You are any age at time of diagnosis **You may NOT be eligible if...** - Your breast cancer diagnosis was more than 5 years ago - You do not have triple negative breast cancer or a qualifying gene mutation Talk to your doctor to see if this trial is right for you.